Roger Colobran Selected Research

Roger Colobran Research Topics

Disease

7	COVID-19 01/2022 - 10/2020
5	Infections 01/2022 - 01/2018
4	Pneumonia (Pneumonitis) 11/2021 - 10/2020
4	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 09/2021 - 01/2019
4	Graves Disease (Basedow Disease) 01/2019 - 09/2011
2	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022 - 01/2018
2	Common Variable Immunodeficiency 01/2022 - 01/2018
2	Hereditary Complement Deficiency Diseases 01/2019 - 01/2016
2	Thyroid Diseases (Thyroid Disease) 01/2019 - 05/2015
2	Reinfection 01/2018 - 01/2016
2	Hereditary Angioedemas 07/2014 - 02/2014
1	Vasculitis (Vasculitides) 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	VEXAS syndrome 01/2022
1	Relapsing Polychondritis 01/2022
1	Purine Nucleoside Phosphorylase Deficiency 09/2021
1	Melanoma (Melanoma, Malignant) 04/2021
1	Virus Diseases (Viral Diseases) 04/2021
1	Asymptomatic Infections 01/2021
1	Angioedema 01/2020
1	Neoplasms (Cancer) 01/2019
1	Thyroiditis 01/2019
1	Disease Progression 01/2019
1	Rare Diseases (Rare Disease) 01/2019
1	Cytokine Release Syndrome 01/2018
1	Inflammation (Inflammations) 01/2018
1	Complement Factor I Deficiency 11/2017
1	Otitis Media 11/2017
1	Non-alcoholic Fatty Liver Disease 01/2016
1	Multiple Sclerosis 06/2015
1	Prostatitis 06/2015
1	Pelvic Pain 06/2015
1	Hyperthyroidism 05/2015
1	Down Syndrome (Down's Syndrome) 10/2014
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 10/2014
1	Hypothyroidism 10/2014
1	Myocarditis (Carditis) 09/2011
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2011
1	Myasthenia Gravis 09/2011
1	Autoimmune Diseases (Autoimmune Disease) 09/2011

Drug/Important Bio-Agent (IBA)

6	AutoantibodiesIBA 01/2022 - 05/2015
4	AntibodiesIBA 11/2021 - 09/2011
4	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2019 - 09/2011
3	VaccinesIBA 01/2022 - 01/2018
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2020 - 01/2019
2	Interferon Type IIBA 11/2021 - 10/2020
2	InterferonsIBA 04/2021 - 01/2018
2	Blood Proteins (Serum Proteins)IBA 01/2019 - 11/2017
2	chemotactic factor inactivatorIBA 11/2017 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2015
2	AutoantigensIBA 06/2015 - 09/2011
2	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 07/2014 - 02/2014
1	Immunoglobulin A (IgA)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	Purine-Nucleoside PhosphorylaseIBA 09/2021
1	InflammasomesIBA 04/2021
1	HLA-C Antigens (HLA-C)IBA 04/2021
1	Amino Acids FDA Link 03/2021
1	Androgen Receptors (Androgen Receptor)IBA 03/2021
1	Testosterone (Sustanon)FDA Link 03/2021
1	polyglutamineIBA 03/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	CytokinesIBA 01/2021
1	pocapavirIBA 01/2021
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 10/2020
1	Toll-Like Receptor 3IBA 10/2020
1	BradykininIBA 01/2020
1	NucleotidesIBA 01/2019
1	Deubiquitinating EnzymesIBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Complement Factor I (C3b Inactivator)IBA 01/2016
1	Peptides (Polypeptides)IBA 06/2015
1	Thyroglobulin FDA Link 10/2014
1	AntigensIBA 10/2014
1	Messenger RNA (mRNA)IBA 07/2014

Therapy/Procedure

2	Critical Care (Surgical Intensive Care) 11/2021 - 03/2021
2	Therapeutics 03/2021 - 01/2019
1	Immunotherapy 01/2019